Related News
New Chinese drug breaks pain barrier
Print Edition
A new Chinese drug to alleviate patients’ neuropathic pain, or nerve pain, has entered clinical trials, according to the Ministry of Science and Technology yesterday.
The pain reliever SR419 was developed by scientists from the Chinese Academy of Sciences and Shanghai SIMR Biotechnology Co Ltd.
Neuropathic pain, often described as sharp, stinging or burning, is chronic pain caused by damaged nerves or a problem with the nervous system. It is also the result of or accompanied by viral infection, diabetes, chemotherapy and surgeries.
Data shows that the incidence of neuropathic pain among Chinese elderly is 49.8 percent and more than 50 percent in cancer patients. Conventional painkillers are largely ineffective.
Zhang Xu, a CAS academic and lead researcher, has studied neuropathic pain for almost 30 years. Based on his research, the Shanghai company established China’s first complete neuropharmaceutical research and development platform.
The drug proved effective in relieving chronic pain caused by nerve damage. It reduced potential side effects on central nerves and could replace opioids and their morphine-like effects.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
